-
Symbol
-
ELVN on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.001 per share
-
Latest Disclosed Shares Owned
-
3,226,331 shares
-
Security Ownership %
-
5.4%
Venrock Healthcare Capital Partners III, L.P. ownership in Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN)
14 Nov 2025 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,226,331 shares of Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN).
This represents 5.4% ownership of the company.
This is the first filing by Venrock Healthcare Capital Partners III, L.P. disclosing ownership of Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN).